IRCT20150808023559N23招募中2 期
Evaluation of safety and effectiveness of favipiravir in comparison with Tenofovir Alafenamid in hospitalized patients with COVID-19
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 100 years（—）
- 性别
- All
入选标准
- •Diagnosis of COVID-19 based on chest CT scan or positive PCR test for COVID-19
- •Requiring hospitalization
- •Patient's age between 16 and 100 years
- •Signing informed consent form
排除标准
- •Receiving other antiviral medicationsrenal failure
- •Renal failure
研究者
相似试验
招募中
3 期
The evaluation of efficacy of Favipiravir in patients with mild to moderate COVID-19IRCT20201005048936N1Dr. Abidi pharmacutical Co.126
招募中
3 期
The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19IRCT20200506047323N3Bandare-abbas University of Medical Sciences60
招募中
3 期
Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19IRCT20200428047228N1Quality Improvement of Intensive Care Research Center- Shahid Beheshti University50
已完成
不适用
Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virusEbola virus diseaseJPRN-UMIN000016101ational Center for Global Health and Medicine5
招募中
3 期
Evaluation the effects of Favipiravir in COVID-19 patientsCOVID-19 pneumonia.COVID-19, virus identifiedU07.1IRCT20151227025726N14Shahid Beheshti University of Medical Sciences84